Frazier Healthcare has raised $262 million for its latest life sciences venture fund that will back early stage therapeutics companies, according to an SEC document filed on Thursday.
The Seattle-based fund, which follows a similar $377 million fund Frazier raised in 2013, will start making investments in 2016 and will focus on seed and Series A funding for startups, Frazier told Xconomy.
A separate SEC filing indicates Frazier is still raising for another fund, called Frazier Healthcare Growth Buyout Fund. That fundraising hasn’t wrapped up yet, but the firm’s website says that side of the business focuses on investing in older, profitable companies across the medical industry.
Frazier was founded in 1991 by Alan Frazier, a former executive at Immunex. This is the eighth fund for the national firm, which has more than $2 billion in assets under management, 170 healthcare portfolio companies and has backed 35 companies that went on to IPO.
GeekWire has reached out to Frazier for more information about the funds. We will update this post when we hear back.
